Aurora Cannabis (ACB) Other Non-Current Liabilities (2018 - 2025)
Aurora Cannabis (ACB) reported Other Non-Current Liabilities of $14.3 million for Q4 2025, little changed quarter-over-quarter from $14.3 million in Q3 2025.
Aurora Cannabis (ACB) Other Non-Current Liabilities (2018 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 4 years of Other Non-Current Liabilities data on file, last reported at $14.3 million in Q4 2025.
- Other Non-Current Liabilities for Q4 2025 came in at $14.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $14.3 million (changed N/A YoY), and the FY2025 annual result was $33.5 million, changed N/A from the prior year.
- Other Non-Current Liabilities steadied at $14.3 million in Q4 2025 per ACB's latest filing, from $14.3 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $35.5 million in Q2 2025 and troughed at $14.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.29 Mn |
| Sep 30, 2025 | 14.26 Mn |
| Jun 30, 2025 | 35.52 Mn |
| Mar 31, 2025 | 33.52 Mn |
| Sep 30, 2020 | 7.33 Mn |
| Mar 31, 2019 | -163,170.83 |
| Dec 31, 2018 | -164,403.49 |
| Jun 30, 2018 | 867,402.93 |